2002 Saab 9-3 93 Convertible Automatic Nice Se Maintained No Reserve on 2040-cars

Auto blog

Greetings from Trollhattan. I'm Emily, but I'm not a Saab.

What’s Swedish for “never give up”? Saab, apparently. The fondly-remembered car company formerly called just that — and now named NEVS — is only a shell, employing just a limited crew in the land of trolls. But itÂ’s got something to sell, and that something seems like it's really something. ItÂ’s called Emily. The Emily GT exists as six prototype electric cars, according to NEVS, with a combined horsepower rating (per car) of 484 powered by an enormous 175-kilowatt lithium-ion battery thatÂ’s good for 600 miles of range. In development almost since Saab's demise — the company, once owned by General Motors, was closed down in 2010 — the Emily is a very real product and needs a real sponsor, according to NEVS CEO Nina Selander, speaking to Carup. “It is for sale, it is also a joy to be able to show it. It should be allowed to live on, itÂ’s too nice, too good and too modern a car for nothing to come of it. Interested parties are welcome,” she said. Photos of the car show a modern, forward-thrust profile with handsome lines, a look similar to the last Saab 9-5 and VolvoÂ’s S60 (must be a Swedish thing) and a fashionable, sci-fi-ish interior. A hopeful engineer on the project estimates that the car is less than two years away from some kind of series production, but according to the modest NEVS website, the company is currently in “hibernation” even as it continues to solicit buyers for the Emilys. Said Peter Dahl, the Emily project manager, “Many have asked us what we have been doing for 10 years. We have developed 13 different car projects, this is one of them.” Related video: Volvo Saab Automotive History Electric Future Vehicles Classics

Last Saab 9-3 built nets nearly $48,000 at auction

It was among the last Saabs to roll off the production line in Trollhattan, Sweden, is virtually new, and now it has a new owner. The Saab 9-3 Aero Turbo4 we told you about a month ago has sold in an auction for the equivalent of $47,789. As with anything related to the remnants of the legendary Swedish automotive brand, the backstory on this one is a little complicated, starting with the model year. Saab originally ground production to a halt in 2011. This model came about after National Electric Vehicle Sweden (NEVS) acquired the brand out of bankruptcy, and was part of a run of 420 models built starting in late 2013 before NEVS lost the rights to use the Saab name and griffin logo. It was originally set aside for crash testing, but never actually used for that purpose, and mostly sat idle inside the plant, in case NEVS restarted production of combustion vehicles. The 41 miles on the odometer came from running the car on a test track near the Trollhattan plant for photography and video purposes. It features a 2.0-liter turbo-four engine that makes 217 horsepower and 258 pound-feet of torque. It has a two-tone interior with cream leather seats and a dashboard and center console that looks like what you might expect to result from Saab's parts-sharing arrangement under the ownership of bankruptcy-era General Motors. Nowadays, NEVS has financial backing from Chinese investors and is making electric vehicles based on the 9-3 platform and body, just without any Saab badging. It continues to operate the Trollhattan plant and another in Tianjin, China, and it reportedly plans a new plant in Shanghai. NEVS also has partnered with Swedish supercar maker Koenigsegg in a venture to develop new EVs. The 9-3 buyer’s name is Claus Spaangaard. HeÂ’s a Danish car collector and car-repair shop owner who says he already owns two Saab cars. Proceeds from the auction will fund research into sustainable mobility in Sweden, NEVS says.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.